Chinese Journal of Hepatology 2011 Issue 3 Analysis of short-term prognosis on patients with chronic severe hepatitis B using the integrated MELD model

Analysis of short-term prognosis on patients with chronic severe hepatitis B using the integrated MELD model
DONG Fei-bo;ZHOU Jian

..............page:220-221

The role of HO-CO system in the hemodynamic disturbance of cirrhotic rats
YANG Shu-ping;GUO Jin-sheng;WANG Ji-yao;LIN Lin;SHI Rui-hua

..............page:174-177

High rates of HBsAg loss and seroconversion result from prolonged course of pegasys treatment
LI Ming-hui;XIE Yao;LU Yao;QIU Guo-hua;LIU Feng;LI Xing-hong;ZHAO Hui;SONG Shu-jing;GUAN Xiao-ping;CHENG Jun;XU Dao-zhen

..............page:182-185

The study on bacteria invading the intestinal mucosa barrier in mice with fulminant hepatic failure
SONG Hong-li;L(U) Sa;LIU Pei

..............page:214-217

Diagnosis of hepatorenal syndrome
SHANG Jia;CAO Qing

..............page:165-166

The protective effect of liver X receptor activation on hepatic inflammation and ischemic reperfusion injury in rats
WANG Yang-yang;LU Su-cai;GUO Ya-qing;TIAN Yuan;CHEN Lei;ZHAO Ya-min;YAN Hong-jian

..............page:222-223

Study on HBV antigens and IL-12 affecting T cell-mediated immunity in HBsAg carriers
LIN Bing-liang;XIE Dong-ying;XIE Jun-qiang;ZHANG Xiao-hong;MEI Yong-yu;GAO Zhi-liang

..............page:186-190

The early efficacy predictor on lamivudine in the treatment of HBeAg positive chronic hepatitis B
LIU Xue-feng;ZHANG Chang

..............page:218-219

Adjuvant drugs in the treatment of autoimmune liver diseases
MA Hong;DUAN Wei-jia

..............page:234-235

Treatment of chronic hepatitis B with pegylated interferon alfa2a combinated with nucleosides: conference summary
LU Zhi-meng;XIE Qing;ZHANG Da-zhi;ZHUANG Hui;WENG Xin-hua

..............page:228-231

Two special cases with hemochromatosis confirmed by hepatic iron determination
YANG Xiang-yi;YANG Xu;LUO Hong-yu;JIANG Yong-fang;DENG Shi-lin

..............page:226-227

A case report of Niemann-Pick disease complicated with liver injury
WU An-zhao;WANG Ming-ming;ZHANG Xiu-zhen;LIU Chun-hua

..............page:225

Randomized controlled trial of integrated traditional Chinese and western medicine treatment for posthepatitic cirrhotic ascites: a systematic review
CHEN Lei;L(U) Zhi-ping

..............page:205-209

The application of the anti-inflammatory and hepatoprotective drugs on drug-induced liver disease
CHEN Dong-feng;SUN Wen-jing

..............page:232-233

Current situation and management of pregnancy and anti-HBV treatment
PENG Jie;HOU Jin-lin

..............page:236-238

Progress on treatment of hepatorenal syndrome
XU Xiao-yuan;ZHENG Ying-ying

..............page:167-168

A case report of chronic hepatitis C with subclinical hypothyroidism
YANG Ke-li;LI Jian-ping;LIU Yuan-huang;GUAN Yu-juan

..............page:224

xin xi dong tai

..............page:166,213,231,238

Pathogenesis of hepatorenal syndrome
ZHANG Lun-li

..............page:163-164

The role of mir-221/222 in inhibiting endoplasmic reticulum stress-induced human hepatocarcinoma cell apoptosis
LIU You-ping;DUAN Chun-yan;CHEN Chuan-ning;YAN Dong-mei;CHEN Shao-kun;LI Juan;LI Hong;DAI Rong-yang

..............page:191-195

Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients
HUANG Jing;CHEN Xiao-ping;CHEN Xue-fu;CHEN Wen-li;CHEN Ren;MA Xiao-jun;LUO Xiao-dan

..............page:178-181

Clinical advances on hepatorenal syndrome research
WANG Ji-yao

..............page:161-162

Pleomorphism of the myelin-like bodies in the hepatocytes of patients with Dubin-Johnson syndrome complicated with chronic hepatitis B
LU Xiao-bo;LIU Hao;XU Qin;ZHANG Yue-xin;DENG Ze-run;HU An-hua;LIU Wen-jie;L(U) Rong-fu

..............page:210-213

The epithelial to mesenchymal transition and liver fibrosis
WANG Hui;XING Zhi-zhi;JIA Ji-dong

..............page:239-240

Relationship between the polymorphisms of UGT1A6 genes and anti-tuberculosis drug induced hepatic-injury
HAO Jin-qi;CHEN Yi;LI Shi-ming;ZHANG Peng;YU Yan-qin;TANG Gui-yu;FENG Fu-min

..............page:201-204

Effects of non-bioartificial liver support system on Gc-globulin in patients with liver failure
KUANG Yong-ling;YUAN Wei-jie;ZHANG Zheng;XING Tong-hai;YU Qing;LIU Jun;CHEN Lei;LIU Zhi-hui;PENG Zhi-hai

..............page:196-200

Polymorphism of ornithine decarboxylase antizyme inhibitor 1 gene is associated with liver cirrhosis in Chinese hepatitis B patients
PENG Li-jun;GUO Jin-sheng;ZHANG Zhe;SHI Hong;WANG Jian;Scott L.Friedman;John J.Sninsky;WANG Ji-yao

..............page:169-173